341 related articles for article (PubMed ID: 21310918)
1. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy.
Rangasamy S; Srinivasan R; Maestas J; McGuire PG; Das A
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3784-91. PubMed ID: 21310918
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
[TBL] [Abstract][Full Text] [Related]
4. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.
Zhang W; Yan H
Exp Eye Res; 2012 Dec; 105():1-8. PubMed ID: 23059402
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
Navaratna D; McGuire PG; Menicucci G; Das A
Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
[TBL] [Abstract][Full Text] [Related]
8. Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats.
Ohashi H; Takagi H; Koyama S; Oh H; Watanabe D; Antonetti DA; Matsubara T; Nagai K; Arai H; Kita T; Honda Y
Mol Vis; 2004 Aug; 10():608-17. PubMed ID: 15354084
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia-induced effects on glycocalyx components in the retina.
Kaur G; Rogers J; Rashdan NA; Cruz-Topete D; Pattillo CB; Hartson SD; Harris NR
Exp Eye Res; 2021 Dec; 213():108846. PubMed ID: 34801534
[TBL] [Abstract][Full Text] [Related]
10. The effect of hyperglycaemia on permeability and the expression of junctional complex molecules in human retinal and choroidal endothelial cells.
Saker S; Stewart EA; Browning AC; Allen CL; Amoaku WM
Exp Eye Res; 2014 Apr; 121():161-7. PubMed ID: 24594192
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of retinal GLUT1 in diabetes by ubiquitinylation.
Fernandes R; Carvalho AL; Kumagai A; Seica R; Hosoya K; Terasaki T; Murta J; Pereira P; Faro C
Mol Vis; 2004 Aug; 10():618-28. PubMed ID: 15359219
[TBL] [Abstract][Full Text] [Related]
12. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
13. A three-pore model describes transport properties of bovine retinal endothelial cells in normal and elevated glucose.
Lopez-Quintero SV; Ji XY; Antonetti DA; Tarbell JM
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1171-80. PubMed ID: 21357410
[TBL] [Abstract][Full Text] [Related]
14. Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.
Xu X; Zhu Q; Xia X; Zhang S; Gu Q; Luo D
Curr Eye Res; 2004 Apr; 28(4):251-6. PubMed ID: 15259294
[TBL] [Abstract][Full Text] [Related]
15. COMP-Ang1 Stabilizes Hyperglycemic Disruption of Blood-Retinal Barrier Phenotype in Human Retinal Microvascular Endothelial Cells.
Rochfort KD; Carroll LS; Barabas P; Curtis TM; Ambati BK; Barron N; Cummins PM
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3547-3555. PubMed ID: 31415078
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.
Liu H; Lessieur EM; Saadane A; Lindstrom SI; Taylor PR; Kern TS
Diabetologia; 2019 Dec; 62(12):2365-2374. PubMed ID: 31612267
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
[TBL] [Abstract][Full Text] [Related]
18. Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats.
Xu H; Cai M; Zhang X
Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1485-92. PubMed ID: 25371107
[TBL] [Abstract][Full Text] [Related]
19. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier.
Giebel SJ; Menicucci G; McGuire PG; Das A
Lab Invest; 2005 May; 85(5):597-607. PubMed ID: 15711567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
